BioDelivery Sciences International (BDSI)

Create an Alert
4.54 -0.12  -2.58%   NASDAQ Jun 19, 5:00PM BATS Real time Currency in USD

BioDelivery Sciences International Gross Profit Margin Quarterly:

76.88% for March 31, 2013
View Full Chart

BioDelivery Sciences International Gross Profit Margin Quarterly Chart

    BioDelivery Sciences International Historical Gross Profit Margin Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 76.88%
    Dec. 31, 2012 96.05%
    Sept. 30, 2012 80.00%
    June 30, 2012 97.70%
    March 31, 2012 97.73%
    Dec. 31, 2011 -14.09%
    Sept. 30, 2011 43.42%
       
    June 30, 2011
    March 31, 2011 -29.62%
    Dec. 31, 2010 98.55%
    Sept. 30, 2010 91.03%
    June 30, 2010 64.06%
    March 31, 2010 94.53%
    Dec. 31, 2009 96.75%

    About Gross Profit Margin

    A gross profit margin is the difference between sales and the cost of goods sold divided by revenue. This represents the percentage of each dollar of a company's revenue available after accounting for cost of goods sold.

    If a company produces phones and earns $32 million in sales but pays $24 million for the items sold, then the company's gross profit margin would be ($32M - $24M) / $32M = 25 percent.

    Cutting costs result in higher gross profit margins. If a company sells phones for 500 dollars and the cost of the producing the phone is $250, the current gross profit margin is 50 percent ((500-250)/500). If the company is able to reduce production costs from $250 to $200, the gross profit margin is 60 percent ((500-200)/500).

    Note : Profit margins are very dependent on sector. Companies that sell bland potato chips may not have very high margins, but will sell a sizable quantity of potato chips. A company that sells consulting services will likely have higher profit margins, but sell lower quantities.
    Learn More

    Get data for

    BDSI Gross Profit Margin Quarterly Benchmarks

    Companies
    Cempra
    AMAG Pharmaceuticals 83.55%
    Chelsea Therapeutics International

    BDSI Gross Profit Margin Quarterly Rankings

    Overall 96th percentile
    634 of 16782
    Sector 90th percentile
    128 of 1410 in Healthcare
    Industry 87th percentile
    57 of 454 in Biotechnology

    BDSI Gross Profit Margin Quarterly Range, Past 5 Years

    Minimum -29.62% Mar 2011
    Maximum 98.55% Dec 2010
    Average 68.69%

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');